Home > PS Ratio > ERIS LIFESCIENCES

ERIS LIFESCIENCES
PS (Price/Sales) Ratio

The Current P/S Ratio of ERIS LIFESCIENCES is 7.99.

Share Price ₹1,466.8Nov 27,2024
Market Cap ₹19,962.5 Cr
Sales-TTM₹2,498.1 CrTTM-Consolidated Results
Price/Sales7.99xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of ERIS LIFESCIENCES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ERIS LIFESCIENCES is calculated as :

Current Market Cap [ ₹19,962.5 Cr] as on Nov 27,2024

(/) Sales [ ₹2,498.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 7.99x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay '7.99 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ERIS LIFESCIENCES !

The chart below summarizes the trend in P/S Ratio of ERIS LIFESCIENCES over the last five years.

Historical PS (Price/Sales) ratio chart of ERIS LIFESCIENCES


PS Ratio Performance Analysis for ERIS LIFESCIENCES

- ERIS LIFESCIENCES 's latest p/e ratio is 7.99x.

- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.74x.

- ERIS LIFESCIENCES 's operated at median p/e ratio of 5.7x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2022 at 6.95x.

- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 4.62x.


How does ERIS LIFESCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ERIS LIFESCIENCES 2,498.17.9919,962.5
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.34419,764.0
CIPLA LTD26,512.04.54120,459.0
DR REDDYS LABORATORIES LTD30,084.93.33100,168.0
ZYDUS LIFESCIENCES LTD21,483.54.4595,662.7
DIVIS LABORATORIES LTD8,614.018.49159,306.0
MANKIND PHARMA LTD11,018.09.29102,379.0
TORRENT PHARMACEUTICALS LTD11,225.09.72109,086.0
LUPIN LTD21,431.34.2791,526.9
AUROBINDO PHARMA LTD30,295.02.3571,087.2
ABBOTT INDIA LTD6,066.19.6458,446.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ERIS LIFESCIENCES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.35x
Max industry PS 18.49x
Median industry PS 7.99x
Average industry PS 7.49x



You may also like the below Video Courses